The sphingosine kinase 1 inhibitor 2-(P-hydroxyanilino)-4-(P-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells
Loveridge, Carolyn and Tonelli, Francesca and Leclercq, Tamara and Lim, Keng Gat and Long, Jaclyn S and Berdyshev, Evgeny and Tate, Rothwelle J and Natarajan, Viswanathan and Pitson, Stuart M and Pyne, Nigel J and Pyne, Susan (2010) The sphingosine kinase 1 inhibitor 2-(P-hydroxyanilino)-4-(P-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells. Journal of Biological Chemistry, 285 (50). pp. 38841-38852. ISSN 1083-351X (https://doi.org/10.1074/jbc.M110.127993)
Full text not available in this repository.Request a copyAbstract
Sphingosine kinase 1 (SK1) is an enzyme that catalyses the phosphorylation of sphingosine to produce the bioactive lipid sphingosine 1-phosphate (S1P). We demonstrate here that the SK1 inhibitor, SKi (2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole) induces the proteasomal degradation of SK1 in human pulmonary artery smooth muscle cells, androgen-sensitive LNCaP prostate cancer cells, MCF-7 and MCF-7 HER2 breast cancer cells and that this is likely mediated by ceramide as a consequence of catalytic inhibition of SK1 by SKi. Moreover, SK1 is polyubiquitinated under basal conditions, and SKi appears to increase the degradation of SK1 by activating the proteasome. In addition, the proteasomal degradation of SK1a and SK1b in androgen-sensitive LNCaP cells is associated with the induction of apoptosis. However, SK1b in LNCaP-AI cells (androgen-independent) is less sensitive to SKi-induced proteasomal degradation and these cells are resistant to SKi-induced apoptosis, thereby highlighting the ubiquitin-proteasomal degradation of SK1 as an important mechanism controlling cell survival.
ORCID iDs
Loveridge, Carolyn, Tonelli, Francesca, Leclercq, Tamara, Lim, Keng Gat, Long, Jaclyn S, Berdyshev, Evgeny, Tate, Rothwelle J, Natarajan, Viswanathan, Pitson, Stuart M, Pyne, Nigel J ORCID: https://orcid.org/0000-0002-5657-4578 and Pyne, Susan ORCID: https://orcid.org/0000-0002-6608-9584;-
-
Item type: Article ID code: 28069 Dates: DateEvent10 December 2010PublishedSubjects: Medicine > Internal medicine > Neoplasms. Tumors. Oncology (including Cancer)
Medicine > Therapeutics. Pharmacology
Science > Microbiology > ImmunologyDepartment: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Miss Shauna Thompson Date deposited: 13 Oct 2010 10:51 Last modified: 11 Nov 2024 09:34 URI: https://strathprints.strath.ac.uk/id/eprint/28069